Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Pickhardt

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Macromolecular Bioscience|May 11, 2017
Gaining Insights into Specific Drug Formulation Additives for Solubilizing a Potential Anti-Alzheimer Disease Drug B4A1Carmen Lawatscheck, Marcus Pickhardt, Anna Grafl, et al.
Current Alzheimer Research|June 25, 2005
Screening for inhibitors of tau polymerizationMarcus Pickhardt, Martin von Bergen, Zuzana Gazova, et al.
Neurobiology of Aging|January 15, 2019
Screening of a neuronal cell model of tau pathology for therapeutic compoundsMarcus Pickhardt, Michele Tassoni, Philip Denner, et al.
Journal of the American Chemical Society|January 31, 2013
Inhibition of tau filament formation by conformational modulationElias Akoury, Michal Gajda, Marcus Pickhardt, et al.
ACS Chemical Neuroscience|June 27, 2018
Structural Basis of Small Molecule Targetability of Monomeric Tau ProteinRóbert Kiss, Georgina Csizmadia, Katalin Solti, et al.
Biochemistry|August 10, 2007
Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cellsMarcus Pickhardt, Gregor Larbig, Inna Khlistunova, et al.
Planta Medica|July 1, 2009
Antimicrobial, antiproliferative, cytotoxic, and tau inhibitory activity of rubellins and caeruleoramularin produced by the phytopathogenic fungus Ramularia collo-cygniSebastian Miethbauer, Friedemann Gaube, Ute Möllmann, et al.
The Journal of Biological Chemistry|October 26, 2005
Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugsInna Khlistunova, Jacek Biernat, Yipeng Wang, et al.
Chemmedchem|October 19, 2007
Curcumin-derived pyrazoles and isoxazoles: Swiss army knives or blunt tools for Alzheimer's disease?Rajeshwar Narlawar, Marcus Pickhardt, Stefanie Leuchtenberger, et al.
Journal of Alzheimer'S Disease : JAD|September 6, 2011
N'-benzylidene-benzohydrazides as novel and selective tau-PHF ligandsAli Taghavi, Samir Nasir, Marcus Pickhardt, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Macromolecular Bioscience|May 11, 2017
Gaining Insights into Specific Drug Formulation Additives for Solubilizing a Potential Anti-Alzheimer Disease Drug B4A1Carmen Lawatscheck, Marcus Pickhardt, Anna Grafl, et al.
Current Alzheimer Research|June 25, 2005
Screening for inhibitors of tau polymerizationMarcus Pickhardt, Martin von Bergen, Zuzana Gazova, et al.
Neurobiology of Aging|January 15, 2019
Screening of a neuronal cell model of tau pathology for therapeutic compoundsMarcus Pickhardt, Michele Tassoni, Philip Denner, et al.
Journal of the American Chemical Society|January 31, 2013
Inhibition of tau filament formation by conformational modulationElias Akoury, Michal Gajda, Marcus Pickhardt, et al.
ACS Chemical Neuroscience|June 27, 2018
Structural Basis of Small Molecule Targetability of Monomeric Tau ProteinRóbert Kiss, Georgina Csizmadia, Katalin Solti, et al.
Biochemistry|August 10, 2007
Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cellsMarcus Pickhardt, Gregor Larbig, Inna Khlistunova, et al.
Planta Medica|July 1, 2009
Antimicrobial, antiproliferative, cytotoxic, and tau inhibitory activity of rubellins and caeruleoramularin produced by the phytopathogenic fungus Ramularia collo-cygniSebastian Miethbauer, Friedemann Gaube, Ute Möllmann, et al.
The Journal of Biological Chemistry|October 26, 2005
Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugsInna Khlistunova, Jacek Biernat, Yipeng Wang, et al.
Chemmedchem|October 19, 2007
Curcumin-derived pyrazoles and isoxazoles: Swiss army knives or blunt tools for Alzheimer's disease?Rajeshwar Narlawar, Marcus Pickhardt, Stefanie Leuchtenberger, et al.
Journal of Alzheimer'S Disease : JAD|September 6, 2011
N'-benzylidene-benzohydrazides as novel and selective tau-PHF ligandsAli Taghavi, Samir Nasir, Marcus Pickhardt, et al.
Pageof 3